Delhi, India, June 2026 — Poly Medicure Ltd has welcomed Indranil Mukherjee as CEO – APAC & India, effective 1 June 2026. In this role, he will lead operations across India and the Asia Pacific region, driving commercial growth, market expansion, and strategic partnerships at a pivotal phase in the company’s growth journey.
Indranil brings over 30 years of leadership experience in the medical technology sector, with a strong track record of scaling businesses, leading transformation, and delivering sustainable outcomes. Prior to joining Poly Medicure, he served as Group Chief Executive Officer at Translumina Therapeutics, where he led the organization’s business and growth agenda.
Before Translumina Therapeutics, Indranil held board and industry leadership responsibilities with MTaI (Medical Technology Association of India) and the Indo-German Chamber of Commerce, contributing to the broader medical technology and business ecosystem.
Earlier, he spent over two decades with B. Braun Group, where he held several senior leadership roles across India, Asia Pacific, Korea, Taiwan, Germany, and Malaysia. His roles included Managing Director, Regional Head – Hospital Care: Asia Pacific, Country Manager – HC & OPM, Regional Head – Korea & Taiwan, Global Sales Manager – Critical Care, and multiple business development and product leadership positions.
He also served as Chairman – Healthcare Sector at European Business Group India, further strengthening his industry leadership experience across healthcare, medical devices, and international business.
About Poly Medicure Ltd
Poly Medicure Limited (Polymed) is a leading Indian medical device company with a strong position in the medical consumables market. The company focuses on innovation, safety, and quality, and serves customers in over 100 countries with a portfolio of more than 125 product types.
Its product range includes infusion therapy, central venous catheters, blood management systems, surgery and wound drainage, anaesthesia, urology, gastroenterology, and dialysis. The company operates five domestic manufacturing facilities and three overseas manufacturing facilities in China, Egypt, and Italy.
With strong R&D initiatives, Poly Medicure has been granted more than 215 product and process patents globally and has filed for over 250 additional patents. The company has also been recognized as the highest exporter of consumable medical devices from India for the last six years and has received the “India Medical Device Company of the Year” recognition from the DoP, Government of India.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
